<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">39759156X</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164940.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199602  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1093/jac/37.2.295</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1093/jac/37.2.295</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Spencer</subfield>
   <subfield code="D">Robert C.</subfield>
   <subfield code="u">Public Health Laboratory, Level 8, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, UK</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="3">
   <subfield code="a">An 8 year Microbe Base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Robert C. Spencer]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Over the last 8 years selected United Kingdom hospitals have contributed antimicrobial susceptibility data to a central data base called Microbe Base. During that period, data on 1,000,067 isolates have been collected, including 29,425 isolates of Pseudomonas aeruginosa. The present study focused on the epidemiology, frequency and antibiotic susceptibility of P. aeruginosa isolates (17,440) from hospitalised patients. In such patients P. aeruginosa was predominant in general surgery (20%), care of the elderly (18%), general medicine (13%), and paediatrics and neonates (10%). Ninety-five per cent of P. aeruginosa were susceptible in vitro to ceftazidime compared with 93% for piperacillin, 92% for gentamicin, 90% for ciprofloxacin, and 89% for imipenem. Excluding susceptibility data reported in 1991, there was no change in the susceptibility pattern of P. aeruginosa throughout the study period.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© 1996 The British Society for Antimicrobial Chemotherapy</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Original articles</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Journal of Antimicrobial Chemotherapy</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">37/2(1996-02), 295-301</subfield>
   <subfield code="x">0305-7453</subfield>
   <subfield code="q">37:2&lt;295</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">37</subfield>
   <subfield code="o">jac</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1093/jac/37.2.295</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1093/jac/37.2.295</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">100</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Spencer</subfield>
   <subfield code="D">Robert C.</subfield>
   <subfield code="u">Public Health Laboratory, Level 8, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, UK</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Journal of Antimicrobial Chemotherapy</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">37/2(1996-02), 295-301</subfield>
   <subfield code="x">0305-7453</subfield>
   <subfield code="q">37:2&lt;295</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">37</subfield>
   <subfield code="o">jac</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
